Novolog (Pharm-Up 1966) Ltd reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was ILS 438.05 million compared to ILS 413.2 million a year ago. Net income was ILS 12 million compared to net loss of ILS 10.43 million a year ago.

Basic earnings per share from continuing operations was ILS 0.024 compared to basic loss per share from continuing operations of ILS 0.021 a year ago. Diluted earnings per share from continuing operations was ILS 0.024 compared to diluted loss per share from continuing operations of ILS 0.021 a year ago.